Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.5850 (-8.17%) ($7.5850 - $7.5850) on Tue. Dec. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.4% (three month average) | RSI | 79 | Latest Price | $7.5850(-8.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 12.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.7% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) EDOC(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.7% (StdDev 5.4%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $8.17(-7.16%) | 10 Day Moving Average | $8.07(-6.01%) | 20 Day Moving Average | $6.9(9.93%) | To recent high | -11% | To recent low | 50.6% | Market Cap | $1.338b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |